Science Says

Tuesday, June 15, 2021

Curing cancer for all: Increasing equity, access, and diversity

A person's race or ethnic background, gender or zip code shouldn’t determine whether they live or die from cancer, COVID-19 or any other disease. Join us for Science Says on Tuesday, June 15, for a wide-ranging discussion about Fred Hutch's role in reducing health disparities and increasing diversity in research by:

  • Reducing unnecessary deaths through increased access to prevention, screening, early diagnosis, treatment, and care.
  • Boosting representation of minorities in genomic studies and clinical trials to improve outcomes.
  • Preparing the next generation of diverse scientists to drive scientific innovation in ways we can scarcely imagine today.

We know our supporters care about curing cancer for all people. Come learn how we're using our best science to ensure everyone has access to advances in cancer prevention, treatment, and cures.

Thank you to our Science Says partner UMC.

Date:
Tuesday, June 15, 2021
Start Time:
9 a.m. PDT
Location:
Virtual
Speaker or Presenter:
Drs. Thomas Lynch Jr., Paul Buckley, Rachel Ceballos, Jeanne Chowning, Riki Peters and Stephaun Wallace

Speakers

Dr. Thomas J. Lynch Jr.

Dr. Thomas J. Lynch Jr.

Dr. Thomas J. Lynch Jr., Fred Hutch president and director and holder of the Raisbeck Endowed Chair, is a lung cancer physician and scientist known around the world for his pioneering role in precision medicine. Since he joined the Hutch in February 2020, he has guided our research and the organization’s response to the pandemic with urgency, compassion, and a commitment to sparking scientific solutions.

Dr. Paul Buckley

Dr. Paul Buckley

Dr. Paul Buckley, vice president and chief diversity and inclusion officer, spearheads efforts to make the Hutch's science and culture more inclusive and diverse. His team coordinates and facilitates initiatives in four core areas: expanding the Hutch's health disparities research capacity; diversifying our workforce; enhancing our climate and culture through educational experiences; and strengthening relationships with local, regional, national, and international communities.

Dr. Rachel Ceballos

Dr. Rachel Ceballos

Dr. Rachel Ceballos studies health disparities in underserved communities to address high incidences of cancer and low screening rates. She works to develop culturally adapted interventions to fight stress and fend off cancer and other diseases like diabetes, heart disease, and COVID-19, which strike Black, Hispanic, and Indigenous populations harder than communities with better access to care and resources.

Dr. Jeanne Chowning

Dr. Jeanne Chowning

Dr. Jeanne Chowning is senior director of Science Education. She provides strategic oversight to educational programs that expose undergraduate, high school students, and teachers to cutting-edge molecular biology and topics such as DNA technologies, cancer research, and health inequities. The inclusive and culturally relevant programs attract students who are the first in their families to attend college and those who belong to racial or ethnic groups that are underrepresented in scientific careers.

Dr. Ulrike "Riki" Peters

Dr. Ulrike "Riki" Peters

Dr. Ulrike "Riki" Peters, a molecular and genetic epidemiologist, is associate director of the Public Health Sciences Division and holder of the Fred Hutch 40th Anniversary Endowed Chair. A pioneer in using large data sets to improve and customize cancer screenings, her research focuses on the interplay between genetic and environmental factors in colorectal cancer as well as the impact that inadequate data from underserved racial and ethnic groups has on risk prediction. 

Dr. Stephaun Wallace

Dr. Stephaun Wallace

Dr. Stephaun Wallace is the director of external relations for the COVID-19 Prevention Network and the HIV Vaccine Trials Network, both based at Fred Hutch. His research sits at the intersection of public health and social justice, with a focus on ensuring key stakeholders and communities that bear the greatest burden of disease are involved in informing the design and implementation of vaccine studies.

Last Modified, September 21, 2021